Emad Behboudi

10PUBLICATIONS
14CO-AUTHORS
Immunogenetics (incl. genetic immunology)Molecular targetsMajor global burdens of diseaseCancer therapy (excl. chemotherapy and radiation therapy)Cardiology (incl. cardiovascular diseases)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Sep 24, 2026
Association of IFN-γ +874 T/A Polymorphism With COVID-19 Susceptibility, Severity, and Inflammatory Response: A Case-Control Study From Southern Iran.

|Feb 17, 2025
The Interplay Between Viral Infection and Cell Death: A Ping-Pong Effect.

Alireza Nourazarian, Hadi Yousefi, Cigir Biray Avci

|Jan 22, 2024
The role of HLA genetic variants in COVID-19 susceptibility, severity, and mortality: A global review.

Taraneh Hoseinnezhad, Nasrin Soltani, Sarina Ziarati

|Oct 03, 2022
Letter to the Editor Regarding "An Overview on Serology and Molecular Tests for COVID-19: An Important Challenge of the Current Century (doi: 10.22034/iji.2021.88660.1894.)".

Milad Zandi, Emad Behboudi, Mohammad Reza Shojaei

|May 31, 2022
Live-attenuated poliovirus-induced extrinsic apoptosis through Caspase 8 within breast cancer cell lines expressing CD155.

Hossein Vazeh, Emad Behboudi, Anahita Hashemzadeh-Omran

|Sep 30, 2021
Association between blood groups and COVID-19 outcome in Iranian patients.

Ali Asghar Ayatollahi, Bahman Aghcheli, Abolfazl Amini

Pageof 2

Frequent Collaborators

1 joint publications

Amrollah Shamsi

1 joint publications

Hadiseh Heidari

1 joint publications

Abdolhalim Rajabi

1 joint publications

Alireza Tahamtan